Detalhe da pesquisa
1.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med
; 384(20): 1899-1909, 2021 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33951374
2.
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.
Lancet HIV
; 9(5): e309-e322, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35489376
3.
Best practices for managing quality and safety of foreign particles in orally inhaled and nasal drug products, and an evaluation of clinical relevance.
Pharm Res
; 24(3): 471-9, 2007 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17252189